| PERIOD ENDING | 30-Jun-09 | 31-Mar-09 | | Total Revenue | 3 | 1 | | Cost of Revenue |
-
|
-
| | | Gross Profit | 3 | 1 | | | Operating Expenses | | Research Development | |
-
|
-
| | Selling General and Administrative | | 355 | 1,376 | | Non Recurring | |
-
|
-
| | Others | |
-
|
-
| | | Total Operating Expenses | |
-
|
-
| | | | Operating Income or Loss | (352) | (1,375) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | | 10 | 15 | | Earnings Before Interest And Taxes | | (342) | (1,360) | | Interest Expense | | 0 | 0 | | Income Before Tax | | (342) | (1,361) | | Income Tax Expense | |
-
|
-
| | Minority Interest | |
-
|
-
| | | Net Income From Continuing Ops | | (342) | (1,361) | | | Non-recurring Events | | Discontinued Operations | |
-
|
-
| | Extraordinary Items | |
-
|
-
| | Effect Of Accounting Changes | |
-
|
-
| | Other Items | |
-
|
-
| | | | Net Income | (342) | (1,361) | | Preferred Stock And Other Adjustments |
-
|
-
| | | Net Income Applicable To Common Shares | ($342) | ($1,361) |
|
